Skip to content

Insights

Thought Leadership

GATC Health brings together visionary scientists, technologists, and entrepreneurs—driven by a shared mission to transform the biopharma industry and a bold vision of a future where effective treatment is within reach for every disease.

Latest Insights (Articles)

AI-Derived Therapeutic Development for the Treatment of Opioid Use Disorder

Biosimilar trial failed? Investors get their money back: a new insurance model redefines clinical trial financing

Autologous Antigen-Specific Immunotherapy (AASI): Precision Immune Re-education in Autoimmunity and Beyond

Video Library

From Addiction to Innovation: Dr. Stephen Loyd on Fighting the Opioid Crisis with AI

From Addiction to Innovation: Dr. Stephen Loyd on Fighting the Opioid Crisis with AI

Dr. Stephen Loyd shares his journey from addiction recovery to innovation in addiction medicine with AI.
GATC Health – COO Tyrone Lam Explains the AI-Based Molecule Discovery Model

GATC Health – COO Tyrone Lam Explains the AI-Based Molecule Discovery Model

Tyrone Lam details GATC's AI-driven approach to molecule discovery.
GATC Health: Accelerating the Future of Medicine with AI – Breakthrough in Opioid Use Disorder

GATC Health: Accelerating the Future of Medicine with AI – Breakthrough in Opioid Use Disorder

Opioid Use Disorder (OUD) is a chronic brain disease that causes compulsive opioid use, leading to dependence, withdrawal, and often fatal …